BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Rosiglitazone
,
rs6983267
,
MYC
,
Apoptosis
,
Influenza
,
Leukocyte
,
Hematopoietic cell
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
6 ohda
Summary
General Info
Curated Studies
Most Correlated Studies
Striata of rats with Parkinson's disease after zonisamide and levodopa treatment
Striata of parkinsonian rats with subthalamic nucleus high frequency stimulation (STN-HFS)
Drd2 and Drd1a spiny projection neurons parkinsonian treated with high and low dose DOPA
iPSC-derived dopaminergic progenitor cells
Explore Curated Studies Results
Literature
Most Relevant Literature
Establishment of a 6-OHDA Induced Unilaterally Lesioned Male Wistar Rat Model of Parkinson's Disease…
Knocking down GRAMD1C expression reduces 6-OHDA-induced apoptosis in PC12 cells.
Peptidomics of Zebrafish Brain in a 6-OHDA-Induced Neurodegeneration Model.
Effect of quercetin and desferrioxamine on 6-hydroxydopamine (6-OHDA) induced neurotoxicity in stria…
Acyl-Ghrelin Attenuates Neurochemical and Motor Deficits in the 6-OHDA Model of Parkinson's Disease.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Phase 2A Study of GM 608 in Mild to Moderate Parkinson Disease
Study of Memantine for Gait Disorders And Attention Deficit In Parkinson's Disease
Dopaminergic restauratIon by intraVEntriculaire Administration
Clinical Study of Droxidopa in Patients With Neurogenic Orthostatic Hypotension (NOH)
TD-9855 Phase 2 in Neurogenic Orthostatic Hypotension (nOH)
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ